A form of ketamine has been approved to treat severe depression Getty
LAST week, the US Food and Drug Administration approved a form of ketamine for use in treatment-resistant depression. This is a landmark moment. Esketamine, as it is known, is the first novel drug therapy for depression to emerge in over 50 years.
People will administer the esketamine themselves, under the supervision of a healthcare professional, by squirting it up their nose. At first they will take it a few times a week, then monthly.
Given that ketamine use can escalate to addiction, there are fears that people…
Article amended on 12 March 2019
We clarified in the headline that it is a form of ketamine that is involved
